DST-funded start-ups develops electrochemical ELISA test for Covid antibody concentration While qualitative analysis detects constituent elements in the sample, semi-quantitative analysis gives an approximate estimation of their concentrations. NEW DELHI: A Bengaluru-based start-up has developed a novel, point-of-care electrochemical ELISA test that enables fast and accurate estimation of total antibody concentration of COVID-19 in clinicalRead more about DST-funded start-ups develops electrochemical ELISA test for Covid antibody concentration[…]

Spacetech startup Bellatrix Aerospace successfully tests India’s first privately built Hall Thruster Spacetech startup Bellatrix Aerospace’s Hall Thruster is a highly efficient electric propulsion system that’s ideal for microsatellites weighing 50kg to 500kg and can be scaled up for heavier satellites. Bellatrix is working towards flying this thruster on a satellite mission in the comingRead more about Spacetech startup Bellatrix Aerospace successfully tests India’s first privately built Hall Thruster[…]

IISc startup PathShodh gets regulatory approvals for COVID-19 Test PathShodh has received the license to manufacture the test for sale from the CDSCO, after due diligence validation at the Translational Health Science and THSTI, Faridabad, as per the requirements of the ICMR. PathShodh Healthcare, a startup incubated at the Society for Innovation and Development (SID)Read more about IISc startup PathShodh gets regulatory approvals for COVID-19 Test[…]

Indian Institute of Science develops new Covid-19 antibody test The IISc developed a semi-quantitative electrochemical ELISA test for Covid-19. The test can determine levels of Covid-induced IgM and IgG antibodies. The researchers at the Bengaluru-based Indian Institute of Science (IISc) have developed a new Covid-19 antibody test machine. The IISc developed a semi-quantitative electrochemical ELISARead more about Indian Institute of Science develops new Covid-19 antibody test[…]

IISc start-up gets regulatory approvals for new COVID-19 test A COVID-19 test developed by PathShodh Healthcare, a start-up incubated at the Society for Innovation and Development (SID), Indian Institute of Science (IISc), has received the license to manufacture the test for sale from the Central Drugs Standard Control Organisation (CDSCO). The test is touted toRead more about IISc start-up gets regulatory approvals for new COVID-19 test[…]

IISc developing oxygen concentrator, vaccine for Covid patients The premier Bengaluru-based Indian Institute of Science (IISc) is developing a low-cost oxygen concentrator and anti-Covid vaccine, Karnataka Health Minister K. Sudhakar said on Thursday. Bangalore: “IISc researchers are designing a low-cost and efficient oxygen concentrator and developing a vaccine for treating Covid patients,” said Sudhakar afterRead more about IISc developing oxygen concentrator, vaccine for Covid patients[…]